Doctors are unaware of the overall prevalence of RAS mutations in Pancreatic Ductal Adenocarcinoma Cancer (PDAC), especially given the lack of treatment options. The objective here was to create a disease awareness campaign that creates a direct link between RAS mutations and Pancreatic cancer, with the hope that upcoming innovations from Revolution Medicines will someday provide a treatment. The vines that spell out RAS on the pancreas have a tight grip with the intention of only getting tighter.